Fulcrum Therapeutics Q1 Earnings Call Highlights [Yahoo! Finance]
Fulcrum Therapeutics, Inc. (FULC)
Last fulcrum therapeutics, inc. earnings: 3/5 07:00 am
Check Earnings Report
Company Research
Source: Yahoo! Finance
7.1% to 19.3% at 12 weeks, improving hemolysis and anemia markers, reducing vaso-occlusive crises (7 of 12 patients had no VOCs), and was generally well tolerated with no treatment-related serious adverse events reported. Fulcrum has started an open-label long-term dosing trial and plans a potential registration-enabling trial in H2 2026 after an end-of-phase FDA meeting, with ongoing discussions about using HbF as a surrogate endpoint and expected global interactions with the EMA. Financially, Fulcrum reported a Q1 net loss of $22.2 million and ended the quarter with $333.3 million in cash and securities, which management says should fund operations into ; corporate changes include a new board appointment and the planned retirement of CFO Alan Musso later this year. Interested in Fulcrum Therapeutics, Inc.? Here are five stocks we like better. Fulcrum Therapeutics (NASDAQ:FULC) highlighted new clinical and corporate progress during its first-quarter 2026 financial results and
Show less
Read more
Impact Snapshot
Event Time:
FULC
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
FULC alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
FULC alerts
High impacting Fulcrum Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
FULC
News
- Fulcrum (FULC) Q1 2026 Earnings Transcript [Globe and Mail, The (Toronto, Canada)]Globe and Mail, The
- Fulcrum Therapeutics Shares Climb After Q1 Earnings Outperform Expectations [Yahoo! Finance]Yahoo! Finance
- Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for First Quarter 2026 [Yahoo! Finance]Yahoo! Finance
- Fulcrum Therapeutics GAAP EPS of -$0.25 beats by $0.05 [Seeking Alpha]Seeking Alpha
- Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for First Quarter 2026GlobeNewswire
FULC
Earnings
- 4/27/26 - Beat
FULC
Analyst Actions
- 2/24/26 - Leerink Partners
FULC
Sec Filings
- 4/27/26 - Form 10-Q
- 4/27/26 - Form 8-K
- 3/26/26 - Form SCHEDULE
- FULC's page on the SEC website